These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28261590)

  • 41. Radiofrequency ablation in the management of unresectable intrahepatic cholangiocarcinoma.
    Fu Y; Yang W; Wu W; Yan K; Xing BC; Chen MH
    J Vasc Interv Radiol; 2012 May; 23(5):642-9. PubMed ID: 22525022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.
    Wang LJ; He CC; Sui X; Cai MJ; Zhou CY; Ma JL; Wu L; Wang H; Han SX; Zhu Q
    Oncotarget; 2015 Mar; 6(8):5932-46. PubMed ID: 25803229
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Surgical management of intrahepatic cholangiocarcinoma in the modern era: advances and challenges.
    Konstantinidis IT; Arkadopoulos N; Ferrone CR
    Chin Clin Oncol; 2016 Feb; 5(1):9. PubMed ID: 26932433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery.
    Miwa S; Miyagawa S; Kobayashi A; Akahane Y; Nakata T; Mihara M; Kusama K; Soeda J; Ogawa S
    J Gastroenterol; 2006 Sep; 41(9):893-900. PubMed ID: 17048054
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching Analysis.
    Gong ZJ; Cheng JW; Gao PT; Huang A; Sun YF; Zhou KQ; Hu B; Qiu SJ; Zhou J; Fan J; Yang XR
    Oncologist; 2019 Jul; 24(7):997-1007. PubMed ID: 30910867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiofrequency ablation of intrahepatic cholangiocarcinoma: feasability, local tumor control, and long-term outcome.
    Butros SR; Shenoy-Bhangle A; Mueller PR; Arellano RS
    Clin Imaging; 2014; 38(4):490-494. PubMed ID: 24637151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatic radiofrequency ablation of metastatic ovarian granulosa cell tumors.
    Jacobs IA; Chang CK; Salti G
    Am Surg; 2003 May; 69(5):416-8. PubMed ID: 12769214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multidisciplinary management of intrahepatic cholangiocarcinoma: Current approaches.
    Guro H; Kim JW; Choi Y; Cho JY; Yoon YS; Han HS
    Surg Oncol; 2017 Jun; 26(2):146-152. PubMed ID: 28577720
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Survival analysis of intrahepatic cholangiocarcinoma after resection.
    Cho SY; Park SJ; Kim SH; Han SS; Kim YK; Lee KW; Lee SA; Hong EK; Lee WJ; Woo SM
    Ann Surg Oncol; 2010 Jul; 17(7):1823-30. PubMed ID: 20165987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.
    Hyder O; Marques H; Pulitano C; Marsh JW; Alexandrescu S; Bauer TW; Gamblin TC; Sotiropoulos GC; Paul A; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Popescu I; Gigot JF; Mentha G; Feng S; Pawlik TM
    JAMA Surg; 2014 May; 149(5):432-8. PubMed ID: 24599477
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise.
    Saha SK; Zhu AX; Fuchs CS; Brooks GA
    Oncologist; 2016 May; 21(5):594-9. PubMed ID: 27000463
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recurrent intrahepatic cholangiocarcinoma: single-center experience using repeated hepatectomy and radiofrequency ablation.
    Kamphues C; Seehofer D; Eisele RM; Denecke T; Pratschke J; Neumann UP; Neuhaus P
    J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):509-15. PubMed ID: 20714840
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stereotactic radiofrequency ablation.
    Bale R; Widmann G; Haidu M
    Cardiovasc Intervent Radiol; 2011 Aug; 34(4):852-6. PubMed ID: 20734193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Percutaneous ultrasound-guided radiofrequency ablation of intrahepatic cholangiocarcinoma.
    Chiou YY; Hwang JI; Chou YH; Wang HK; Chiang JH; Chang CY
    Kaohsiung J Med Sci; 2005 Jul; 21(7):304-9. PubMed ID: 16089307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resection for intrahepatic cholangiocellular cancer: new advances.
    Waisberg DR; Pinheiro RS; Nacif LS; Rocha-Santos V; Martino RB; Arantes RM; Ducatti L; Lai Q; Andraus W; D'Albuquerque LC
    Transl Gastroenterol Hepatol; 2018; 3():60. PubMed ID: 30363713
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Precancerous lesions of intrahepatic cholangiocarcinoma.
    Shimonishi T; Sasaki M; Nakanuma Y
    J Hepatobiliary Pancreat Surg; 2000; 7(6):542-50. PubMed ID: 11180885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Case: Authentic multimodal therapy and liver resection for an initially unresectable intrahepatic cholangiocarcinoma.
    Sakata K; Kijima D; Yamaguchi T; Furuhashi T; Abe T; Iwamoto H; Morita K
    Int J Surg Case Rep; 2018; 51():409-414. PubMed ID: 30273909
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transarterial Chemoembolization: A Favorable Postoperative Management to Improve Prognosis of Hepatitis B Virus-associated Intrahepatic Cholangiocarcinoma after Surgical Resection.
    Jeong S; Zheng B; Wang J; Chi J; Tong Y; Xia L; Xu N; Zhang J; Kong X; Gu J; Xia Q
    Int J Biol Sci; 2017; 13(10):1234-1241. PubMed ID: 29104490
    [No Abstract]   [Full Text] [Related]  

  • 59. Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
    Uenishi T; Ariizumi S; Aoki T; Ebata T; Ohtsuka M; Tanaka E; Yoshida H; Imura S; Ueno M; Kokudo N; Nagino M; Hirano S; Kubo S; Unno M; Shimada M; Yamaue H; Yamamoto M; Miyazaki M; Takada T
    J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):499-508. PubMed ID: 24519806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management and outcomes among patients with mixed hepatocholangiocellular carcinoma: A population-based analysis.
    Spolverato G; Bagante F; Tsilimigras D; Ejaz A; Cloyd J; Pawlik TM
    J Surg Oncol; 2019 Mar; 119(3):278-287. PubMed ID: 30554420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.